A risk assessment of antibiotic pan-drug-resistance in the UK: Bayesian analysis of an expert elicitation study

Antibiotics

Volumn 6, Issue 1, 2017, Pages

  Carter, Daniel ^a   Charlett, André ^a   Conti, Stefano ^a   Robotham, Julie V ^a   Johnson, Alan P ^a   Livermore, David M ^b   Fowler, Tom ^a   Sharland, Mike ^c   Hopkins, Susan ^a   Woodford, Neil ^a   Burgess, Philip ^d   Dobra, Stephen ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d Health Protection Analytical Team   (United Kingdom)

Author keywords

Antibiotic resistance; Bayesian modelling; Risk assessment

Indexed keywords

CARBAPENEM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BAYES THEOREM; GRAM NEGATIVE BACTERIUM; HEALTH CARE DELIVERY; HEALTH IMPACT ASSESSMENT; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; LENGTH OF STAY; MONTE CARLO METHOD; MORTALITY RATE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; UNITED KINGDOM;

EID: 85016311967     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics6010009     Document Type: Article

References (31)

1. De Kraker, M.E.A.; Davey, P.G.; Grundmann, H. on behalf of the BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: Estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011, 8, e1001104.
2. European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe 2014. Available online: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51--4aed-4d32-b960-af70113dbb90&ID=1400 (accessed on 18 November 2016).
3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available online: http://www.cdc.gov/drugresistance/threat-report-2013 (accessed on 18 November 2016).
4. Australian Government. Responding to the Threat of Antimicrobial Resistance. Commonwealth of Australia, 2015. Available online: http://www.health.gov.au/internet/main/publishing.nsf/content/1803C433C71415CACA257C8400121B1F/\protect\T1\textdollarFile/amr-strategy-2015--2019.pdf(accessed on 18 November 2016).
5. WHO. The Evolving Threat of Antimicrobial Resistance. Options for Action. Available online: http://apps.who.int/iris/bitstream/10665/44812/1/9789241503181_eng.pdf (accessed on 18 November 2016).
6. Davies, S.C. Annual Report of the Chief Medical Officer, Volume Two, 2011. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138331/CMO_Annual_Report_Volume_2_2011.pdf (accessed on 18 November 2016).
7. Department of Health. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf(accessed on 18 November 2016).
8. O’Hagan, A.; Buck, C.E.; Daneshkhah, A.; Eiser, J.R.; Garthwaite, P.H.; Jenkinson, D.J.; Oakley, J.E.; Rakow, T. Uncertain Judgements: Eliciting Experts’ Probabilities; John Wiley & Sons: Chichester, UK, 2006.
9. Bernardo, J.M.; Smith, A.F.M. Bayesian Theory, 2nd ed.; John Wiley & Sons: Chicester, UK, 2000.
10. Gelman, A.; Carlin, J.B.; Stern, H.S.; Dunson, D.B.; Vehtari, A.; Rubin, D.B. Bayesian Data Analysis, 3rd ed.; Chapman & Hall/CRC: Boca Raton, FL, USA, 2014.
11. Kennedy, M.C.; Clough, H.E.; Turner, J. Case studies in Bayesian microbial risk assessment. Environ. Health 2009, 8.
12. The Global Economic Impact of Anti-Microbial Resistance. Available online: https://www.kpmg.com/UK/en/IssuesAndInsights/ArticlesPublications/Documents/PDF/Issues%20and%20Insights/amr-reportfinal.pdf(accessed on 18 November 2016).
13. Estimating the Economic Costs of Antimicrobial Resistance. Model and Results. Available online: http://www.rand.org/content/dam/rand/pubs/research_reports/RR900/RR911/RAND_RR911.pdf(accessed on 18 November 2016).
14. Livermore, D.M.; Hope, R.; Reynolds, R.; Blackburn, R.; Johnson, A.P.; Woodford, N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: Links to prescribing change? J. Antimicrob. Chemother. 2013, 68, 2667–2674.
15. Giani, T.; Pini, B.; Arena, F.; Conte, V.; Bracco, S.; Migliavacca, R. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: Results of the first countrywide survey, 15 May to 30 June 2011. Euro. Surveill. 2013, 30, 2–10.
16. ECDC. Surveillance Atlas of Infectious Disease. Available online: http://atlas.ecdc.europa.eu/public/index.aspx?Instance=GeneralAtlas(accessed on 18 November 2016).
17. Findlay, J.; Hopkins, K.L.; Doumith, M.; Meunier, D.; Wiuff, C.; Hill, R.; Pike, R.; Loy, R.; Mustafa, S.; Livermore, D.M., et al. KPC enzymes in the UK: An analysis of the first 160 cases outside the North-West region. J. Antimicrob. Chemother. 2016, 71, 1199–1206.
18. Leavitt, A.; Chmelnitsky, I.; Carmeli, Y.; Navon-Venezia, S. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob. Agents Chemother. 2010, 54, 4493–4496.
19. Bonura, C.; Giuffrè, M.; Aleo, A.; Fasciana, T.; Di Bernardo, F.; Stampone, T.; Giammanco, A. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of multiple non-ST258 clones. PLoS ONE 2015, 10, e0132936.
20. European Centre for Disease Prevention and Control/EuropeanMedicines Agency. The Bacterial Challenge: Time to React. European Centre for Disease Prevention and Control: Stockholm, 2009. Available online: http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf(accessed on 18 November 2016).
21. Shallcross, L.J.; Davies, S.C. TheWorld Health Assembly resolution on antimicrobial resistance. J. Antimicrob. Chemother. 2014, 69, 2883–2885.
22. WHO. High-Level Meeting on Antimicrobial Resistance. Available online: http://www.un.org/pga/71/2016/09/21/press-release-hl-meeting-on-antimicrobial-resistance/(accessed on 18 November 2016).
23. Oakley, J.E.; O’Hagan, A. SHELF: The Sheffield Elicitation Framework (version 2.0), School of Mathematics and Statistics, University of Sheffield, UK, 2010. Available online: http://tonyohagan.co.uk/shelf(accessed on 18 November 2016).
24. Morris, D.E.; Oakley, J.E.; Crowe, J.A. A web-based tool for eliciting probability distributions from experts. Environ. Model. Softw. 2014, 52, 1–4.
25. British Society for Antimicrobial Chemotherapy Resistance Surveillance Project. Available online: http://www.bsacsurv.org/reports/bacteraemia(accessed on 18 November 2016).
26. Hospital Episode Statistics: Admitted Patient Care, England—2012-13. Available online:http://content.digital.nhs.uk/catalogue/PUB12566/hosp-epis-stat-admi-summ-rep-2012--13-rep.pdf(accessed on 18 November 2016).
27. Crowley, L.; Pitcher, D.; Wilson, J.; Guy, R.; Fluck, R. UK Renal Registry 16th Annual Report: Chapter 15 Epidemiology of Reported Infections amongst Patients Receiving Dialysis for Established Renal Failure in England from May 2011 to April 2012: A Joint Report from Public Health England and the UK Renal Registry. UK Renal Registry: Bristol, 2013. Available online:http://www.renalreg.com/Reports/2013.html(accessed on 18 November 2016).
28. Public Health England. Surgical Site Infection Reports. Available online: http://webarchive.nationalarchives.gov.uk/20140722091854/http://www.hpa.org.uk/Publications/InfectiousDiseases/SurgicalSiteInfectionReports/(accessed on 18 November 2016).
29. Reuter, S.; Kern, W.V.; Sigge, A.; Dohner, H.; Marre, R.; Kerm, P.; von Baum, H. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin. Infect. Dis. 2005, 40, 1087–1093.
30. Maraha, B.; Bonten, H.; van Hooff, H.; Fiolet, H.; Buiting, A.G.; Stobberingh, E.E. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin. Microbiol. Infect. 2001, 7, 619–625.
31. Almallah, Y.Z.; Rennie, C.D.; Stone, J.; Lancashire, M.J. Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology 2000, 56, 37–39.